SLRX vs XPEV · $4.9M cap vs rev $895.7M
Salarius Pharmaceuticals Inc (SLRX) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
SLRX currently screens at market cap $4.9M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the SLRX and XPEV stock pages for the full models.
Not investment advice.